Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
autologous cytokine rich serum
- Development stage
- Unknown
- Lead developer
- Tecnologia Regenerativa Qrem
- Administration
- Injection
01
Overview
Autologous Cytokine Rich Serum (CRS) is an investigational biologic therapy developed for the treatment of chronic lateral epicondylitis (tennis elbow). It is an autologous blood-derived product prepared using the Q-Cytokine medical device, which processes the patient's own blood through a series of centrifugation steps to concentrate cytokines and growth factors released from platelets and leukocytes. These proteins are intended to facilitate the repair and regeneration of injured tendon tissue. The therapy is administered via local injection into the lateral epicondyle and is being evaluated as a less invasive alternative to arthroscopic resection surgery.
- Other names
- CRScytokine rich serum
02
Targets
IL1R1 (Interleukin-1 Receptor Type 1)IL10RA (Interleukin-10 Receptor)TGFBR (TGF-beta receptor)TNFRSF1A (Tumor necrosis factor receptor superfamily member 1A)IL10 (Interleukin-10)
Beyond the preview
Go deeper on autologous cytokine rich serum.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on autologous cytokine rich serum.